A Multi-Center, Randomized, Placebo-Controlled, Double Blind, Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 with Lucassin (Terlipressin)

  • Angulo, Paul (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date6/23/11 → 5/31/13